DFE Pharma, a global leader in pharmaceutical excipients, has announced the launch of its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in formulation development, optimisation, and lifecycle management of CM processes.
In collaboration with Gericke, a leading international company in high precision feeding, blending, and powder processing equipment, this initiative combines CM-ready excipients, flexible CM evaluation environment, and multidisciplinary expertise, enabling data-driven decisions from early exploration through optimisation and long-term operation of CM.
As part of the CM platform, DFE Pharma has invested in continuous manufacturing capability at its C2F Center of Excellence in Hyderabad featuring a Gericke Formulation Skid (GFS).
This state-of-the-art formulation skid, with modular feeding and blending options, is placed in a non-GMP environment, enabling fast iterations and practical assessment and optimization without disrupting existing GMP manufacturing or requiring upfront infrastructure investment.
The modular setup at the C2F Center supports flexible process and formulations testing by combining the GFS with pre-blending and downstream process and analytical capabilities to generate decision-relevant insights.
This equipment gives pharmaceutical companies the opportunity to experience how continuous feeding and blending operate in practice, test formulation strategies using CM-ready materials, and learn how evaluation data translates directly into real world implementation.
